medline.ch Dermatologie Tumoren Melanom

	Narrow Excision Margins for Diverse Histological Subtypes of Cutaneous Melanoma in Children and Adults: A Systematic Review. Dermatol Ther (Heidelb) Balado-Simó P, Mansilla-Polo M, Morgado-Carrasco D. PMID: 41735604 [PubMed - as supplied by publisher]
	Emerging biomarkers in melanoma: Bridging molecular discovery and precision oncology. Cancer Lett Xu S, Huang Z, Li Y, Lu L, Ma W. PMID: 41734832 [PubMed - as supplied by publisher]
	No robust evidence supporting an association between tattoos and de-novo cutaneous melanoma. Eur J Epidemiol Kluger N. PMID: 41733775 [PubMed - as supplied by publisher]
	A mixed inflammatory peripheral signature defines clinical outcomes in a phase II trial combining pembrolizumab with paclitaxel and carboplatin in melanoma. Oncoimmunology Lambert C, Jamal R, Thébault P, Cocolakis E, Bélanger K, Dionne J, Cailhier JF, Le H, Letendre C, Lepage S, Shechtman Y, Lapointe R, Miller WH Jr. PMID: 41732954 [PubMed - indexed for MEDLINE]
	Managing Close and Involved Margins Following Excision of Non-Melanoma Skin Cancer: A Retrospective Cohort Study. Australas J Dermatol Matheus IG, Wagels M. PMID: 41730679 [PubMed - as supplied by publisher]
	Lifestyle Medicine Strategies for Reducing Risk of Melanoma: Modifiable Factors and Clinical Implications. Am J Lifestyle Med Alaswad L, Galiatsatos P, Srivastava G. PMID: 41727279 [PubMed - as supplied by publisher]
	31-Gene expression profiling for cutaneous melanoma: an expert consensus panel. Dermatol Online J Burshtein J, Cockerell C, Cotter D, Farberg A, Ferris L, Kaufmann M, Leachman S, Rizzo J, Schlesinger T, Shah M, DeBusk L, Rosenberg A, Bartley B, Lebwohl M, Rigel D. PMID: 41725468 [PubMed - indexed for MEDLINE]
	Endâ€‘ofâ€‘life care in advanced melanoma: a retrospective cohort study from an Italian comprehensive cancer center. BMC Cancer De Mattia M, Boutros A, Delucchi V, Blondeaux E, Lambertini M, Lagodin D'Amato A, Giannubilo I, Del Mastro L, Pronzato P, Bighin C, Spagnolo F, Tanda ET. PMID: 41723391 [PubMed - as supplied by publisher]
	Gut microbial signatures and immunotherapy outcomes in NSCLC and melanoma: a systematic review and meta-analysis. BMC Cancer Essa MEA, Noori H, Butler J, Ahmed AA. PMID: 41723389 [PubMed - as supplied by publisher]
	Clinical impact of butterbur shoot extract in dogs with oral melanoma: a combined phase 1 and 2 clinical trial. BMC Vet Res Noguchi S, Furuya M, Honda K, Ito R, Akao Y. PMID: 41721401 [PubMed - as supplied by publisher]
	Prognostic significance and clinicopathological association of tumor budding and poorly differentiated clusters in cutaneous malignant melanoma. Virchows Arch Xie YL, He S, Rehman S, Lu SY, Ke LF, Zhang WW, Chen Y, Chen G, Chen YP. PMID: 41718769 [PubMed - as supplied by publisher]
	Natural compounds as immune checkpoint inhibitors in melanoma: a systematic review. Naunyn Schmiedebergs Arch Pharmacol Samieefar S, Arasteh O, Yeganeh Khorasanii N, Abedi F, Hosseinzadeh HR, Hosseinzadeh H. PMID: 41718747 [PubMed - as supplied by publisher]
	Does tumor-infiltrating lymphocyte therapy improve survival outcomes in patients with advanced melanoma? Front Med (Lausanne) Ridley-Parish P. PMID: 41716797 [PubMed]
	Oral amelanotic melanoma in a 73-year-old patient: A rare case report and literature review. J Clin Exp Dent de Arruda JA, Drumond VZ, Abreu LG, de Cáceres CV, Vargas PA, Caldeira PC, Fonseca FP, Mesquita RA, de Andrade BA, Silva TA. PMID: 41716371 [PubMed]
	Impact of adjuvant anti-PD-1 immunotherapy on ovarian function in female patients with resectable melanoma: A prospective observational study. Eur J Cancer Pedersen S, Colmorn LB, Ellebaek E, Kristensen SG, Ruhlmann C, Borch TH, Donia M, Fedder J, Macklon KT, Svane IM. PMID: 41713079 [PubMed - as supplied by publisher]
	Cutaneous melanoma histopathologic features and laboratory findings as predictors of sentinel lymph node status and progression-free survival: a single-center experience. Acta Dermatovenerol Alp Pannonica Adriat Panti, Pantovi, Kotur M, Petri, Radivojevi, Petrovi, Vujo, Gruji, Grozdi, , Artiko V, Odalovi. PMID: 41712199 [PubMed - indexed for MEDLINE]
	Correction to "Advances in the noninvasive diagnosis of melanoma-40 years beyond the ABCDs". CA Cancer J Clin PMID: 41711686 [PubMed - in process]
	SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial. Acta Oncol Helgadottir H, Carneiro A, Portelli F, Papadakis K, Björkström K, Yang M, Johansson I, Skogvall Svensson I, Jazrawi A, Hallgren A, Harbst K, Bark R, Egyhazi Brage S, Berglund A, Isaksson K, Wickström S, Nilsson J, Ny L, Jönsson G, Olofsson Bagge R, SWE-NEO Study Group. PMID: 41711492 [PubMed - in process]
	Rational Design and Responsive Transdermal Cargo Delivery of Microneedles in the Treatment of Melanoma. Int J Nanomedicine Cai M, Jia Y, Fu T, Kong J, Qiu Y, Zhao Y, Li X, Yang Y, Bai D. PMID: 41710366 [PubMed - indexed for MEDLINE]
	Effective inhibition of lung metastatic melanoma by pH-responsive lipopeptide/PLGA hybrid nanoparticles silencing PD-L1 with augmented suppression of the AKT/Î²-catenin pathway. J Mater Chem B Yang Z, Wang S, Song Z, Guo R, Ding D, Gao Y, Qiao M. PMID: 41709848 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 45198

Seite 1 von 2260

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung